Search results
There he led a prominent clinical and research program known for its excellence in innovation, care and leadership in Translational Medicine. Dr. Litvack was board-certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology.
Feb 3, 2016 · Dr. Litvack is a Co-Founder and General Partner in Pura Vida Investments LLC, a health care focused Hedge Fund. In addition he sits on the Boards of several early stage health care companies.
Frank Litvack M.D. is a native of Montreal, Canada. He received his undergraduate and medical education at McGill University. He received his MD in 1979 at the age of twenty-three. Dr. Litvack completed his residency in Internal Medicine at McGill.
Apr 16, 2018 · To interview Dr. Litvack, contact Brian Donohue at UW Medicine: 206.543.7856; bdonohue@uw.edu. For details about UW Medicine, please visit http://uwmedicine.org/about. As syphilis patient cases increase, so, too, do related cases of hearing loss and tinnitus.
Dr. Litvack joined the Capricor, Inc. board in 2012 and since November 2013 has been serving as the Company’s Executive Chairman. Dr. Litvack is a native of Canada.
CRF recently selected two new members to its Board of Directors: Karen G. Krasney, JD, and Frank Litvack, MD. The appointments increase the number of directors to 12. Ms. Krasney is Executive Vice President and General Counsel for Capricor Therapeutics, Inc. Dr. Litvack is Director of Strategy and Alternative Investments at Pura Vida ...
Since 2000, Dr. Litvack has been a Professor of Medicine at University of California, Los Angeles. From 1989 until 1997, Dr. Litvack was a founder and director of Progressive Angioplasty Systems Inc., which was acquired by United States Surgical Corporation.
